Journey Medical Corporation announced that the Company has entered into a credit facility with an affiliate of SWK Holdings Corporation providing for borrowings of up to $20 million. The Credit Facility provides for an initial term loan of $15 million that the Company intends to use to fund general corporate operations and commercial and DFD-29 product development initiatives. The Company also has the option to draw an additional tranche of $5 million under the Credit Facility, subject to the achievement of specified operational and financial metrics, in the twelve months following the date of the credit facility.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.14 USD | +3.21% |
|
-4.46% | -10.76% |
13/05 | Transcript : Journey Medical Corporation, Q1 2024 Earnings Call, May 13, 2024 | |
13/05 | Journey Medical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.76% | 9.97Cr | |
+54.61% | 81TCr | |
+44.25% | 65TCr | |
-6.33% | 35TCr | |
+20.62% | 34TCr | |
+10.44% | 30TCr | |
+18.45% | 25TCr | |
+2.09% | 23TCr | |
+13.03% | 22TCr | |
+8.61% | 17TCr |
- Stock Market
- Equities
- DERM Stock
- News Journey Medical Corporation
- Journey Medical Corporation Secures Credit Facility with SWK Holdings for Up to $20 Million